Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Proc Natl Acad Sci U S A ; 111(1): E109-18, 2014 Jan 07.
Artículo en Inglés | MEDLINE | ID: mdl-24367096

RESUMEN

Adaptive immunity is initiated in T-cell zones of secondary lymphoid organs. These zones are organized in a rigid 3D network of fibroblastic reticular cells (FRCs) that are a rich cytokine source. In response to lymph-borne antigens, draining lymph nodes (LNs) expand several folds in size, but the fate and role of the FRC network during immune response is not fully understood. Here we show that T-cell responses are accompanied by the rapid activation and growth of FRCs, leading to an expanded but similarly organized network of T-zone FRCs that maintains its vital function for lymphocyte trafficking and survival. In addition, new FRC-rich environments were observed in the expanded medullary cords. FRCs are activated within hours after the onset of inflammation in the periphery. Surprisingly, FRC expansion depends mainly on trapping of naïve lymphocytes that is induced by both migratory and resident dendritic cells. Inflammatory signals are not required as homeostatic T-cell proliferation was sufficient to trigger FRC expansion. Activated lymphocytes are also dispensable for this process, but can enhance the later growth phase. Thus, this study documents the surprising plasticity as well as the complex regulation of FRC networks allowing the rapid LN hyperplasia that is critical for mounting efficient adaptive immunity.


Asunto(s)
Fibroblastos/citología , Ganglios Linfáticos/inmunología , Ganglios Linfáticos/metabolismo , Linfocitos/citología , Inmunidad Adaptativa , Animales , Movimiento Celular , Proliferación Celular , Células Dendríticas/citología , Fibroblastos/metabolismo , Homeostasis , Inflamación , Activación de Linfocitos , Linfotoxina-alfa/metabolismo , Ratones , Ratones Endogámicos C57BL , Microscopía Fluorescente/métodos , Factor 88 de Diferenciación Mieloide/metabolismo , Células del Estroma/citología , Linfocitos T/citología
2.
J Immunol ; 188(6): 2914-21, 2012 Mar 15.
Artículo en Inglés | MEDLINE | ID: mdl-22308310

RESUMEN

Syndecan is the major transmembrane proteoglycan in cells. Of the four syndecans, syndecan-1 is the dominant form expressed in multiple myeloma and is an indicator of poor prognosis. In the current study, we observed that early TRAIL-induced apoptotic processes were accompanied by cleavage of syndecan-1 intracellular region, and explored the possibility whether removal of syndecan-1 promotes apoptotic processes. We found that syndecan-1 knockdown by specific small interfering RNA in multiple myeloma enhanced TRAIL-induced apoptosis, even though the expression of TRAIL receptors and several apoptosis-associated molecules was unaffected. The enhanced TRAIL-mediated apoptosis in syndecan-1-deficient cells was not due to a decrease in surface heparan sulfate or a reduction in TRAIL receptor endocytosis. The increase in TRAIL-induced cell death was accompanied by an elevated caspase-8 activation and an enhanced formation of death-inducing signaling complexes, which could be attributed to an increased expression of TRAIL receptor O-glycosylation enzyme in syndecan-1-deficient cells. We also found that in H9 lymphoma and Jurkat cells, knockdown of the predominant syndecan member also led to an increase in Fas ligand-induced apoptosis. Our results demonstrate that syndecan plays a negative role in death receptor-mediated cell death, suggesting potential application of syndecan downregulation in the treatment of myeloma in combination with TRAIL.


Asunto(s)
Apoptosis/fisiología , Mieloma Múltiple/metabolismo , Sindecano-1/metabolismo , Ligando Inductor de Apoptosis Relacionado con TNF/metabolismo , Proteínas Adaptadoras de Señalización del Receptor del Dominio de Muerte/inmunología , Proteínas Adaptadoras de Señalización del Receptor del Dominio de Muerte/metabolismo , Técnicas de Silenciamiento del Gen , Humanos , Inmunoprecipitación , Mieloma Múltiple/inmunología , ARN Interferente Pequeño , Reacción en Cadena en Tiempo Real de la Polimerasa , Sindecano-1/inmunología , Ligando Inductor de Apoptosis Relacionado con TNF/inmunología
3.
Sci Rep ; 11(1): 1347, 2021 01 14.
Artículo en Inglés | MEDLINE | ID: mdl-33446747

RESUMEN

Iron deficiency anemia (IDA) is a common micronutrient deficiency among pregnant women with severe consequences including impaired immuno-inflammatory system, premature birth, fetal death etc. The present study aimed to investigate the effects of three iron supplements on IDA female rats and their offspring. The IDA female rat model was established with low iron diet and the rats were then mated. After pregnancy, rats were fed diets containing different iron supplements (iron polysaccharide complex, iron protein succinylate and ferrous sulfate) until their offspring were 42 days old. Pregnancy outcomes, haematological, iron metabolism, physical and neurological development indexes were determined. The results showed that all three iron supplements improved the levels of hematological parameters of both mother and offspring rats. After iron supplementation, serum iron, transferrin saturation and serum ferritin levels were increased compared with the IDA group. The level of ferritin light chain in the liver and spleen of both mother and offspring rats in iron supplemented groups was significantly higher than that of the IDA group. The average number of born alive per litter in the iron treatment groups was significantly higher than that in the IDA group. Iron supplements also improved the physical growth and neurobehavioral development of offspring rats. It was also found that iron supplementation improved the expression of ferritin light chain and the synaptic growth associated proteins in the brain and hippocampus. No significant difference was found in the efficacy of three iron supplements. These results suggest that pregnant and postpartum IDA affects pregnancy outcomes, offspring physical development and causes neural impairment. Sufficient iron supplementation can significantly improve IDA and its adverse effects on both mother and offspring.


Asunto(s)
Anemia Ferropénica , Compuestos Ferrosos/farmacología , Metaloproteínas/farmacología , Complicaciones Hematológicas del Embarazo , Resultado del Embarazo , Succinatos/farmacología , Anemia Ferropénica/sangre , Anemia Ferropénica/tratamiento farmacológico , Animales , Femenino , Hierro/farmacología , Embarazo , Complicaciones Hematológicas del Embarazo/sangre , Complicaciones Hematológicas del Embarazo/tratamiento farmacológico , Ratas , Ratas Wistar
4.
Cell Rep ; 15(7): 1527-1541, 2016 05 17.
Artículo en Inglés | MEDLINE | ID: mdl-27160906

RESUMEN

Secondary lymphoid tissues provide specialized niches for the initiation of adaptive immune responses and undergo a remarkable expansion in response to inflammatory stimuli. Although the formation of B cell follicles was previously thought to be restricted to the postnatal period, we observed that the draining mesenteric lymph nodes (mLN) of helminth-infected mice form an extensive number of new, centrally located, B cell follicles in response to IL-4Rα-dependent inflammation. IL-4Rα signaling promoted LTα1ß2 (lymphotoxin) expression by B cells, which then interacted with CCL19 positive stromal cells to promote lymphoid enlargement and the formation of germinal center containing B cell follicles. Importantly, de novo follicle formation functioned to promote both total and parasite-specific antibody production. These data reveal a role for type 2 inflammation in promoting stromal cell remodeling and de novo follicle formation by promoting B cell-stromal cell crosstalk.


Asunto(s)
Formación de Anticuerpos/inmunología , Linfocitos B/metabolismo , Helmintiasis/inmunología , Helmintiasis/parasitología , Parasitosis Intestinales/inmunología , Parasitosis Intestinales/parasitología , Linfotoxina-alfa/metabolismo , Nematospiroides dubius/fisiología , Animales , Proliferación Celular , Quimiocina CCL19/metabolismo , Fibroblastos/metabolismo , Fibroblastos/patología , Subunidad alfa del Receptor de Interleucina-4/metabolismo , Ganglios Linfáticos/parasitología , Ganglios Linfáticos/patología , Receptor beta de Linfotoxina/metabolismo , Ratones Endogámicos C57BL , Transducción de Señal , Células del Estroma/patología , Linfocitos T/inmunología
6.
PLoS One ; 6(11): e27618, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-22110693

RESUMEN

Adaptive immune responses are initiated when T cells encounter antigen on dendritic cells (DC) in T zones of secondary lymphoid organs. T zones contain a 3-dimensional scaffold of fibroblastic reticular cells (FRC) but currently it is unclear how FRC influence T cell activation. Here we report that FRC lines and ex vivo FRC inhibit T cell proliferation but not differentiation. FRC share this feature with fibroblasts from non-lymphoid tissues as well as mesenchymal stromal cells. We identified FRC as strong source of nitric oxide (NO) thereby directly dampening T cell expansion as well as reducing the T cell priming capacity of DC. The expression of inducible nitric oxide synthase (iNOS) was up-regulated in a subset of FRC by both DC-signals as well as interferon-γ produced by primed CD8+ T cells. Importantly, iNOS expression was induced during viral infection in vivo in both LN FRC and DC. As a consequence, the primary T cell response was found to be exaggerated in Inos(-/-) mice. Our findings highlight that in addition to their established positive roles in T cell responses FRC and DC cooperate in a negative feedback loop to attenuate T cell expansion during acute inflammation.


Asunto(s)
Fibroblastos/citología , Fibroblastos/metabolismo , Ganglios Linfáticos/citología , Óxido Nítrico/biosíntesis , Linfocitos T/citología , Animales , Linfocitos T CD8-positivos/citología , Linfocitos T CD8-positivos/inmunología , Linfocitos T CD8-positivos/metabolismo , Proliferación Celular , Células Dendríticas/citología , Células Dendríticas/inmunología , Regulación Enzimológica de la Expresión Génica/inmunología , Interferón gamma/metabolismo , Ratones , Óxido Nítrico Sintasa de Tipo II/deficiencia , Linfocitos T/inmunología , Linfocitos T/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA